Vimarsana
Biggest News Aggregation in the World

Page 21 - Tata Tech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tata Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tata Tech Today - Breaking & Trending Today

tata tech listing: Tata Tech IPO investors make 180% return on Day 1. Should you buy, sell or hold? - Vimarsana News

tata tech listing: Tata Tech IPO investors make 180% return on Day 1. Should you buy, sell or hold?

At a 140% premium over the issue price of Rs 500, Tata Technologies' listing price of Rs 1,200 beat Street's estimates. While the stock was expected to double on the listing, it went far beyond, hitting the day's high of Rs 1,400 on the NSE or a 180% uptick over the upper IPO price band.

Tata Tech closes 165% higher on market debut: A look at 5 stocks that beat the Tata Group stock at listing gains - Vimarsana News

Tata Tech closes 165% higher on market debut: A look at 5 stocks that beat the Tata Group stock at listing gains

The Tata Tech listing was the best listing of 2023 and also the best since November 2021. However, overall till date, some stocks have performed better than this Tata Group stock in listing gains.

Gainers & Losers: IREDA, Aether among top 5 stocks in limelight on Thursday - Vimarsana News

Gainers & Losers: IREDA, Aether among top 5 stocks in limelight on Thursday

For more such web stories click on the ET icon below

After IREDA listing, Tata Tech, Gandhar Oil make stellar debut on the stock market - Vimarsana News

After IREDA listing, Tata Tech, Gandhar Oil make stellar debut on the stock market

The bumper listing comes amid broader euphoria in capital markets

Source: theweek.in
Flair Writing Industries IPO grey market premium increases ahead of listing - Vimarsana News

Flair Writing Industries IPO grey market premium increases ahead of listing

Flair Writing Industries IPO | Citing the grey market price and the above reasons, Rajan Shinde, research analyst at Mehta Equities believes the healthy listing is justified